沙利卢马布治疗复发性多发性肌痛性风湿症:患者报告的3期,双盲,随机对照试验的结果
Vibeke Strand1, Jerome Msihid2, Jennifer Sloane3
1Division of Immunology/Rheumatology, Stanford University, Palo Alto, CA, USA.
The Lancet. Rheumatology
|June 22, 2025
概括
与安慰剂相比,沙利卢马布显著改善了与健康有关的生活质量和患者报告的结局在患有多发性肌痛类风湿症的成年人中. 这表明沙利卢马布对仅用皮质类固醇治疗不足的患者有效.
科学领域:
- 类风湿病学 类风湿病学
- 临床试验 临床试验
- 患者报告的结果
背景情况:
- 多发性肌痛性风湿症 (PMR) 患者往往对皮质类固醇有不充分的反应或不耐受,影响他们的生活质量.
- 沙利卢马布是经批准的PMR治疗方法,但其对患者报告结果的影响需要进一步评估.
研究的目的:
- 评估沙利卢马布对PMR的成年患者患者报告结果的影响.
- 为了比较沙利卢马布与安慰剂在改善PMR患者健康相关生活质量的疗效.
主要方法:
- 第三阶段,双盲,随机对照试验,涉及17个国家的118名成人PMR患者.
- 患者接受皮下沙利卢马布200毫克每2周一次,随着14周的葡萄糖皮质激素逐渐减少或安慰剂,随着52周的葡萄糖皮质激素逐渐减少.
- 患者报告的结果包括HAQ-DI,VAS,SF-36,EQ-5D和FACIT-F被评估到第52周.
主要成果:
- 与安慰剂相比,沙利卢马布组在SF-36物理组件总结 (PCS) 和心理组件总结 (MCS) 得分上显示出显著更大的改善.
- 在沙利卢马布组,EQ-5D实用指数和FACIT-F分数的改善更大.
- 更多接受沙利卢马布治疗的患者报告了SF-36 PCS得分的临床重要改善.
结论:
- 沙利卢马布200毫克每2周一次导致与健康相关的生活质量和PMR患者报告结果的临床上有意义的改善.
- 这些好处在患有更严重疾病的患者中最为明显.
- 这些发现支持沙利卢马布在PMR患者的使用,这些患者的病情不能通过葡萄糖皮质激素单一治疗得到充分控制.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...


